Skip to main content
GRDN logo

Guardian Pharmacy Services, Inc. (GRDN) Stock Price & Analysis

Guardian Pharmacy Services, Inc. (GRDN) — MoonshotScore 96/100 (Exceptional band), calculated Nov 18, 2026. Price $46.94 (+0.58%), as of the Nov 20, 2026 trading session; market cap $2.97B.

Educational signal · not a buy or sell recommendation · How to read this

$46.94 +$0.27 (+0.58%) Market Cap $2.97B

Guardian Pharmacy Services, Inc. · GRDN · NYSE

Guardian Pharmacy Services, Inc. provides technology-enabled pharmacy services to residents in long-term health care facilities (LTCFs) in the United States, focusing on lower acuity facilities. They offer individualized clinical, drug dispensing, and administration capabilities, supported by data-driven insights.

Price as of Nov 20, 2026

Key Statistics

96 of 100

MoonshotScore v2 · Guardian Pharmacy Services (GRDN)

Exceptional
Business Quality Elite (89)
Financial Safety Fortress (94)
Valuation Full (52)
Growth Durability Compounding (97)
Momentum Surging (96)
Why this rating? Method, drivers & history

Bands for the MoonshotScore: Exceptional 80-100 · Strong 65-79 · Fair 45-64 · Weak below 45.

  • Business Quality — Is this a genuinely good business?
  • Financial Safety — Could this blow up on me?
  • Valuation — Am I paying a fair price?
  • Growth Durability — Is the growth real and likely to last?
  • Momentum — Is the market already moving on this?
The ten-second read ·

Elite quality, a fortress balance sheet and elite growth, but a full valuation; the market is already moving on it. Business Quality: Elite; Financial Safety: Fortress; Valuation: Full; Growth Durability: Compounding; Momentum: Surging.

  • EPS beat 0 of the last 4 reports
  • Altman Z 13.15 · Piotroski F 6
  • ROE 32.0% · ROA 13.4% · current ratio 1.65

Helping: business quality, balance-sheet strength, durable growth, positive momentum

What has the MoonshotScore done over time?

MoonshotScore snapshots recorded for GRDN (58 recorded, newest six shown)
RecordedScoreBand
97Exceptional
97Exceptional
97Exceptional
96Exceptional
96Exceptional
96Exceptional

Daily score refresh is delayed. This is the last recorded calculation.

Calculation uses the most recent completed US trading session. Live price changes do not update the score immediately.

Computed · How the MoonshotScore is computed →

Price & valuation

Dates shown where recorded
MeasureValueAs of
Latest provided price$46.94
Change on the day+0.58%
52-week range$26.34 – $50.59
Market capitalisation$2.97B—
Price / earnings (trailing)42.65
Shares traded on the day526.7K

Price & events

Other perspectives

Council score for Guardian Pharmacy Services (GRDN): perspectives

Some lenses disagree with the MoonshotScore. Compare their readings below; each uses a different method.

5-Factor Breakdown

Business Quality Strong
Financial Safety Strong
Valuation Neutral
Growth Durability Strong
Momentum Strong

Legends Council

4 lenses, 4 current

AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built

Griffin-style lens (simulated) Ken Griffin Unfavorable read
Englander-style lens (simulated) Izzy Englander Neutral read
Klarman-style lens (simulated) Seth Klarman Neutral read
Moon AI lens (model) Favorable read

Read on: Nov 20, 2026

Munger's Mindset

Balance Sheet & Valuation

Financial Health Moderate
Margin of Safety Overvalued
Profit Margin Neutral
Debt/Equity Moderate
ROE Strong
Gross Margin Weak

Read on: Nov 20, 2026

How to read these bars and different assessments

Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.

Bars show each model's ordered assessment on its own scale, not a probability or a comparable investment return. The adjacent words give the assessment; more filled segments indicate a stronger model reading.

Two of these lenses read this company less favourably than the MoonshotScore does: Griffin-style lens and Munger lens (margin of safety). Each lens is a separate scoring function over its own inputs, so a disagreement is a difference of method rather than a correction — the page's answer stays the MoonshotScore above.

The Munger lens reads the current price as overvalued against its own estimate of value.

Readings on this page are from Nov 21, 2026, except a card that shows its own read date.

1 · What is it?

What is Guardian Pharmacy Services (GRDN), and what does it report?

Short answer

A current FMP business description is unavailable; the listing and provider classification below are the available identity facts. Guardian Pharmacy Services, Inc. (GRDN) is listed on NYSE. It employs 3,600 people and is led by Fred Burke. The market values it at $2.97B.

2 · Latest results

What do the latest results show for Guardian Pharmacy Services (GRDN)?

Short answer · as of

Against analyst estimates the company has EPS beat 0 of the last 4 reports.

Quarterly income statement — 4 quarters
Revenue, net income and earnings per share by quarter
PeriodRevenueNet incomeEPS
Sep 2025$377M$10M$0.15 (diluted)
Q4 FY2025$398M$21M$0.33 (diluted)
Q1 FY2026$337M$13M$0.21 (diluted)
Q2 FY2026$352M$22M$0.34 (diluted)
3 · Financial strengths and risks

What are the financial strengths and risks for Guardian Pharmacy Services (GRDN)?

Short answer

The MoonshotScore pillars rate business quality, balance-sheet strength, durable growth, positive momentum as strengths. The distress and quality screens read Altman Z 13.15 · Piotroski F 6. Trailing ratios: ROE 32.0% · ROA 13.4% · current ratio 1.65.

4 · What to check next?

What should you watch next at Guardian Pharmacy Services (GRDN)?

Short answer · as of

The stored analyst-target capture is expired, so a current target watchpoint is unavailable.

What the records here don't tell us

  • No forward revenue or earnings estimate is on file.
  • The next earnings date is not yet scheduled in the calendar we read.

Checked against the records this page reads, on the dates shown above.

5 · Peer comparison

How does Guardian Pharmacy Services compare with its peers?

Short answer

Guardian Pharmacy Services's score ranks 1st of 13 in the bounded comparison shown, against 12 same-model peers. These are company scores, not expected investment returns. The set lists named competitors first, then companies in the same data-provider industry classification closest in market value; that classification is the provider's, not our judgment of business similarity.

Peer set — price, market value and MoonshotScore
CompanyPriceMarket valueScore
Guardian Pharmacy Services (GRDN) — this page$46.94$2.97B96
Addus HomeCare Corporation (ADUS) Same industry, near in market value$121.07 Nov 19, 2026$2.26B93 5-pillar Nov 18, 2026
Healthcare Services Group, Inc. (HCSG) Same industry, near in market value$24.77 Nov 19, 2026$1.67B93 5-pillar Nov 18, 2026
LifeStance Health Group, Inc. (LFST) Same industry, near in market value$13.34 Nov 19, 2026$5.07B92 5-pillar Nov 18, 2026
Option Care Health, Inc. (OPCH) Same industry, near in market value$31.61 Nov 19, 2026$4.74B85 5-pillar Nov 18, 2026
Edgewise Therapeutics, Inc. (EWTX) Named competitor$41.17 Nov 19, 2026$4.51B84 5-pillar Nov 18, 2026
Pediatrix Medical Group, Inc. (MD) Same industry, near in market value$29.94 Nov 19, 2026$2.34B82 5-pillar Nov 18, 2026
Ardent Health Partners, LLC (ARDT) Same industry, near in market value$14.50 Nov 19, 2026$2.04B81 5-pillar Nov 18, 2026
National HealthCare Corporation (NHC) Same industry, near in market value$188.55 Nov 19, 2026$2.95B76 5-pillar Nov 18, 2026
Aveanna Healthcare Holdings Inc. (AVAH) Same industry, near in market value$10.70 Nov 19, 2026$2.34B75 5-pillar Nov 18, 2026
MiniMed Group, Inc. Common Stock (MMED) Same industry, near in market value$16.01 Nov 20, 2026$4.50B38 5-pillar Nov 18, 2026
Agilon Health, Inc. (AGL) Same industry, near in market value$89.50 Nov 19, 2026$1.50B36 5-pillar Nov 18, 2026
Surgery Partners, Inc. (SGRY) Same industry, near in market value$26.69 Nov 19, 2026$3.49B35 5-pillar Nov 18, 2026

Only 5-pillar scores are ranked together. Other models are not directly comparable. Price and score dates are shown separately; market-value dates are unavailable.

The records behind this page

Analyst targets & estimates

What analysts have on file

Last captured analyst target range, low to high (expired, captured Nov 18, 2026)
$49.00 – $52.00
Last captured analyst target (expired, captured Nov 18, 2026)
$50.67
Last captured median analyst target (expired, captured Nov 18, 2026)
$51.00

Historical target record · Captured · Capture expired; not a current watchpoint.

Insider activity

Form 4 records via FMP · Of the newest 500 records, those within the last 180 days, newest dated Sep 27, 2026

Transactions
33
Identified insiders
16
Purchases
0
Sales
0
Other transactions
33

Purchases and sales use the reported transaction category. Other transactions include awards, exercises, gifts, withholding and unclassified activity; an acquisition or disposition alone is not a purchase or sale. These records do not establish intent.

Who holds the shares?

Institutional ownership reported through 13F filings.

Tracked investors

Which of the 16 named investors we follow held GRDN in their latest 13F filing, and what they did against the filing before it.

None of the 16 tracked investors reported GRDN in their latest 13F filing.

See all tracked investor portfolios

How to read these figures

These filings arrive after the quarter ends. Names appear as the provider lists them, not as a verified ranking, and without filing dates. Related managers can appear separately, so their shares are not added together. Tracked investors: each fund's own latest 13F, so funds that have not filed the newest quarter yet show their previous one; weight is the share of the fund's reported 13F value.

What has been published about Guardian Pharmacy Services (GRDN)?

Read these with our analysis →

What Investors Ask About Guardian Pharmacy Services (GRDN)

These answers are editorial: 1 of these 9 answers is drawn from the GRDN research dossier (written May 6, 2026 by gemini-2.0-flash); the other 8 are question templates that restate figures shown above. Figures in this section are not part of the source register.

What does the MoonshotScore mean for GRDN?

GRDN carries the MoonshotScore stated above — the Exceptional band. This is an educational research signal, not a buy or sell recommendation. The number comes from the five-pillar engine (business quality, financial safety, valuation, growth durability, momentum), re-ranked daily against sector peers.

Is GRDN a good stock to buy?

Stock Expert AI does not rate GRDN buy, sell or hold. Guardian Pharmacy Services, Inc. carries a MoonshotScore, in the Exceptional band, a research rating against its peers rather than a forecast. Whether it fits is your call: check what it sells, whether it earns and what the price assumes. This is educational content, not investment advice.

What is the GRDN stock price today?

The last price recorded for Guardian Pharmacy Services, Inc. (GRDN), with its trading session and source, is listed under Price & valuation on this page. It is a provider snapshot, not a live exchange feed, so check a brokerage quote before you trade.

What is the GRDN price target?

The last analyst consensus price target we captured for Guardian Pharmacy Services, Inc. (GRDN), with its FMP capture date, is listed under Analyst targets & estimates on this page. That capture has expired, so read it as historical, not as a current target. Targets are analyst opinions, not a Stock Expert AI forecast.

What does Guardian Pharmacy Services, Inc. do?

Guardian Pharmacy Services, Inc. provides technology-enabled pharmacy services to residents in long-term health care facilities (LTCFs) across the United States.

What are the key factors to evaluate for GRDN?

Guardian Pharmacy Services, Inc. (GRDN) holds a MoonshotScore in the high range. To weigh it, start with the trailing P/E under Price & valuation on this page. By aligning its interests with those of LTCF providers, Guardian can strengthen its customer relationships and drive long-term growth. Not financial advice.

How frequently does GRDN data refresh on this page?

GRDN's price is the last quote we recorded, from the Nov 20, 2026 trading session. Pages are served from a cache, so the copy you are reading can lag that quote. The quote is a provider snapshot, not an exchange feed. Fundamentals follow quarterly filings. V2 is recalculated from the most recent completed US trading session; the score's own date shows its last successful run.

What has driven GRDN's recent stock price performance?

Guardian Pharmacy Services, Inc. (GRDN) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Specialized expertise in serving lower acuity LTCFs. See the News tab for the latest drivers. Past performance does not predict future results.

Should investors consider GRDN overvalued or undervalued right now?

The trailing P/E of Guardian Pharmacy Services, Inc. (GRDN) is listed under Price & valuation on this page. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.

Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated May 6, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief.

Sources: the source register lists the 17 figures on this page — 10 from Financial Modeling Prep (FMP), 6 with no recorded source and 1 from Stock Expert AI's own score and rank. Its rows (value as shown, as-of date, tier and source link) are in the Markdown version of this page.

Publication details and research sources
Published
Research standards
Methodology · Editorial policy · Corrections
Data Sources & Methodology
Figures come from Financial Modeling Prep (FMP). If FMP has no figure for a ticker, a price or fundamental may come from a Yahoo Finance fallback, or a price from an Alpaca fallback. SEC EDGAR is used only for filing links and company identity details (legal name, address), never for figures. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.